Stockreport

Axcella Announces Initiation of EMMPACTSM Phase 2b Clinical Trial of AXA1125

Axcella Health Inc.  (AXLA) 
Last axcella health inc. earnings: 3/23 04:01 pm Check Earnings Report
PDF Initial clinical sites activated and patient screening underwayPotential for AXA1125 to serve as a first-line therapy for patients with nonalcoholic steatohepatitis (NAS [Read more]